This study aimed to elucidate how miR-27a-3p modulates the Wnt/-catenin signaling pathway to market colorectal cancer (CRC) progression. declare no potential issues of interest. Dehydroepiandrosterone supplier Referrals 1. White colored BD, Chien AJ, Dawson DW. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal malignancies. Gastroenterology. 2012;142:219C232. [PMC free of charge content] [PubMed] 2. Chambon P. Ten years of molecular biology of retinoic acidity receptors. FASEB J. 1996;10:940C954. [PubMed] 3. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841C850. [PubMed] 4. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-cis retinoic acidity is a Rabbit polyclonal to RB1 higher affinity ligand for the retinoid X receptor. Cell. 1992;68:397C406. [PubMed] 5. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Connection of nuclear receptors using the Wnt/beta-catenin/Tcf signaling axis: Wnt you want to understand? Endocr Rev. 2005;26:898C915. [PubMed] 6. Xiao JH, Ghosn C, Hinchman C, Forbes C, Wang J, Snider N, Cordrey A, Zhao Y, Chandraratna RA. Adenomatous polyposis coli (APC)-self-employed rules of beta-catenin degradation with a retinoid X receptor-mediated pathway. Dehydroepiandrosterone supplier J Biol Chem. 2003;278:29954C29962. [PubMed] 7. Thomas M, Sukhai MA, Kamel-Reid S. An growing part for retinoid X receptor alpha in malignant hematopoiesis. Leuk Res. 2012;36:1075C1081. [PubMed] 8. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis. 2000;21:1271C1279. [PubMed] 9. Han A, Music Z, Tong C, Hu D, Bi X, Augenlicht LH, Yang W. Sulindac suppresses beta-catenin manifestation in human tumor cells. Eur J Pharmacol. 2008;583:26C31. [PMC free of charge content] [PubMed] 10. Zhang F, Meng F, Li H, Dong Y, Yang W, Han A. Suppression of retinoid X receptor alpha and aberrant beta-catenin manifestation significantly affiliates with development of colorectal carcinoma. Eur J Malignancy. 2011;47:2060C2067. [PubMed] 11. Vychytilova-Faltejskova P, Radova L, Sachlova M, Kosarova Z, Slaba K, Fabian P, Grolich T, Prochazka V, Kala Z, Svoboda M, Kiss I, Vyzula R, Slaby O. Serum-based microRNA signatures in early analysis and prognosis prediction of cancer of the colon. Carcinogenesis. 2016;37:941C950. [PubMed] 12. Zhou L, Liang X, Zhang L, Yang L, Nagao N, Wu H, Liu C, Lin S, Cai G, Liu J. MiR-27a-3p features as an oncogene in gastric malignancy by focusing on BTG2. Oncotarget. 2016;7:51943C51954. https://doi.org/10.18632/oncotarget.10460. [PMC free of charge content] [PubMed] 13. Zhao N, Sunlight H, Sunlight B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin manifestation and inhibiting EMT: an important part for Twist-1 in HCC. Sci Rep. 2016;6:23091. [PMC free of charge content] [PubMed] 14. Wu XZ, Wang KP, Music HJ, Xia JH, Jiang Y, Wang YL. MiR-27a-3p promotes esophageal malignancy cell proliferation via F-box and WD do it again domain-containing 7 (FBXW7) suppression. Int J Clin Exp Med. 2015;8:15556C15562. [PMC free of charge content] [PubMed] 15. Nakata W, Uemura M, Sato M, Fujita K, Jingushi K, Ueda Y, Kitae K, Tsujikawa K, Nonomura N. Manifestation of miR-27a-3p can be an self-employed predictive element for recurrence in obvious cell renal cell carcinoma. Oncotarget. 2015;6:21645C21654. https://doi.org/10.18632/oncotarget.4064. [PMC free of charge content] [PubMed] 16. Qiao B, He BX, Cai JH, Tao Q, King-Yin LA. MicroRNA-27a-3p modulates the Wnt/beta-catenin signaling pathway to market epithelial-mesenchymal changeover in dental squamous carcinoma stem cells by focusing on SFRP1. Sci Rep. 2017;7:44688. [PMC free of charge content] [PubMed] 17. Zhang R, Xu J, Zhao J, Bai J. Knockdown of miR-27a sensitizes colorectal malignancy stem cells to Path by promoting the forming of Apaf-1-caspase-9 complicated. Oncotarget. 2017;8:45213C45223. https://doi.org/10.18632/oncotarget.16779. [PMC free of charge content] [PubMed] 18. Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, Milone MR, Budillon A, Santopaolo M, Mazzoccoli G, Matarese G, Sabatino L, Colantuoni V. The miR-27a-calreticulin axis impacts drug-induced immunogenic cell loss of life in human being colorectal tumor cells. Cell Loss of life Dis. 2016;7:e2108. [PMC free of charge content] [PubMed] Dehydroepiandrosterone supplier 19. Bao Y, Chen Z, Guo Y, Feng Y, Li Z, Han W, Wang J, Zhao W, Jiao Y, Li K, Wang Q, Wang J, Zhang H, Wang L, Yang W. Tumor suppressor microRNA-27a in colorectal carcinogenesis and development by focusing on SGPP1 and Smad2. PLoS One. 2014;9:e105991. [PMC free of charge content] [PubMed] 20. Tombolan L, Zampini M, Casara S, Boldrin E, Zin A, Bisogno G,.